Paul E. Zarek

Array ( [id] => 8660107 [patent_doc_number] => 20130040935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'CYCLIC KETO-ENOLS FOR THERAPY' [patent_app_type] => utility [patent_app_number] => 13/578914 [patent_app_country] => US [patent_app_date] => 2011-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 77442 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398483 [patent_doc_number] => 08268862 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Sirtuin modulating compounds' [patent_app_type] => utility [patent_app_number] => 13/012775 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26416 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13012775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413641 [patent_doc_number] => 08697678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Anaesthetic formulation' [patent_app_type] => utility [patent_app_number] => 13/574201 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 13110 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214191 [patent_doc_number] => 20110136816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM' [patent_app_type] => utility [patent_app_number] => 13/006701 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 76531 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136816.pdf [firstpage_image] =>[orig_patent_app_number] => 13006701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398433 [patent_doc_number] => 08268812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections' [patent_app_type] => utility [patent_app_number] => 12/987611 [patent_app_country] => US [patent_app_date] => 2011-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16329 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12987611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10018069 [patent_doc_number] => 09060535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Substituted butanol derivatives and their use as fragrance and flavor materials' [patent_app_type] => utility [patent_app_number] => 12/981758 [patent_app_country] => US [patent_app_date] => 2010-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12124 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12981758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8510423 [patent_doc_number] => 20120309831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'BALANCED FAT COMPOSITION AND USE THEREOF IN A LIQUID NUTRITIONAL COMPOSITION SUITABLE FOR ENTERAL FEEDING' [patent_app_type] => utility [patent_app_number] => 13/514275 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10984 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696108 [patent_doc_number] => 20110230482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/958379 [patent_app_country] => US [patent_app_date] => 2010-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 147252 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230482.pdf [firstpage_image] =>[orig_patent_app_number] => 12958379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9778072 [patent_doc_number] => 08853277 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)' [patent_app_type] => utility [patent_app_number] => 13/512665 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 5866 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202376 [patent_doc_number] => 20110065162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'IRE-1alpha INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/941530 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 32563 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065162.pdf [firstpage_image] =>[orig_patent_app_number] => 12941530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071284 [patent_doc_number] => 20110046135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'NEW COMPOUNDS I' [patent_app_type] => utility [patent_app_number] => 12/917085 [patent_app_country] => US [patent_app_date] => 2010-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22505 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046135.pdf [firstpage_image] =>[orig_patent_app_number] => 12917085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5986828 [patent_doc_number] => 20110098268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'SPIROCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/912094 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40199 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098268.pdf [firstpage_image] =>[orig_patent_app_number] => 12912094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968206 [patent_doc_number] => 08507016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Aloe powder, aloe juice, and method for producing the same' [patent_app_type] => utility [patent_app_number] => 12/925380 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6594 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12925380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8587002 [patent_doc_number] => 20130005824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'TREATMENT OF ISCHEMIC TISSUE' [patent_app_type] => utility [patent_app_number] => 13/502196 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9898 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196098 [patent_doc_number] => 20110027856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY' [patent_app_type] => utility [patent_app_number] => 12/902052 [patent_app_country] => US [patent_app_date] => 2010-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60122 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027856.pdf [firstpage_image] =>[orig_patent_app_number] => 12902052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033468 [patent_doc_number] => 20110082182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'THERAPEUTIC ANTIVIRAL PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/894535 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37998 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082182.pdf [firstpage_image] =>[orig_patent_app_number] => 12894535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064578 [patent_doc_number] => 20110201694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Compositions and Methods for Treatment of Disorders of Protein Aggregation' [patent_app_type] => utility [patent_app_number] => 12/882250 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 25655 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201694.pdf [firstpage_image] =>[orig_patent_app_number] => 12882250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202980 [patent_doc_number] => 20110065766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'METHODS OF USE OF ANTIVIRAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/881038 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21347 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065766.pdf [firstpage_image] =>[orig_patent_app_number] => 12881038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039452 [patent_doc_number] => 20110092501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'NOVEL INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/880369 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 107603 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092501.pdf [firstpage_image] =>[orig_patent_app_number] => 12880369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577806 [patent_doc_number] => 08344016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Pyrazole derivatives as 11-beta-HSD1 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/878416 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44440 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12878416 [rel_patent_id] =>[rel_patent_doc_number] =>)